What's your short thesis aside from level II and Mr. Market signals? Throw me a bone...because shorting this is risky but if it's going to help me make money why not?
You joined Feb 9 2016, and you were the one make sec manipulation type comments so I don't think I'll take your word.
Data looks promising and the stock looks incredibly undervalued. The risk is worth it considering potential market share and market cap. It's not often you stumble across a reformulation that can outperform other drugs in phase 1 and 2s. I'll continue buying leading into the news release.
Your post can be reported to the sec for manipulation. You the individual and the firm's officer in question can be reported in the complaint.
Of all the aml drugs cpxx 351 has the best chance. Check out cpxx their phase 3 topline is almost out.
I like this stock a lot. I have another aml company that's low risk to invest as well. Look at cpxx their phase 3 topline is almost out. They're going to be standard of care like atnm.
I sold my positions....to early to be in this. I was waiting for a deal but it never happened for their pipeline. Try looking at cpxx...their phase 3 cancer topline is almost out.
If there is a reverse merger this stock will be completely diluted for existing shareholders. Look at cpxx, phase 3 cancer topline results are almost out.
GNC is an incredibly irresponsible company for selling products while operating like a flea market. They don't even check if the products meet regulations are safe for consumers. Not to mention, when the FDA had warned them back in 2013 to stop selling products that were proven to be contaminated they ignored and continued selling. Not only did they continue selling but they put those products on sale with "buy out" to clear items from inventory. They don't care about people's health...sad for those who are now suffering.